Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...

These days, one doesn’t experience the news on these platforms before seeing the memes and reactions—the reaction and the ...

We’re here to spotlight the wildest products we’ve found so far at CES 2026, from an AI-powered panda that responds to your ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

Often, when talking about new tech gadgets, the conversation is dominated by skepticism, but some products can really make ...

Quantified finance is the use of numbers to help people and businesses manage their money more effectively. It employs ...

In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated.

Parents, faith communities, neighborhood groups and small business owners are not obstacles to reform; they are essential ...

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...

The apps, wearables and routines that made a big difference to my food and fitness in 2025 that helped me shed 40lbs ...

Cardiologists weigh in on whether your daily water intake can actually move the needle on your lipid panel or if it’s just a ...